Technol Health Care. 2024;32(S1):107-114. doi: 10.3233/THC-248009.
Atopic dermatitis (AD) is a common inflammatory skin disease with a chronic course and a high recurrence.
Based on the theory of "prevention and recovery after ulceration", the application value and significance of compound ginseng cicada decoction in the intervention of chronic disease management in patients with AD were retrospectively analyzed.
Through clinical retrospective observation, 60 patients with spleen deficiency and moisture type AD admitted to the outpatient clinic of our hospital after January 2019 were analyzed. After comprehensive treatment until the patient's Investigator's Global Assessment (IGA) Scale score is lower than 2 points, the study group was divided into a research group and a control group, according to the actual clinical follow-up whether to take compound ginseng cicada soup. The control group carried out chronic disease management education, conventional emollient topical with no drug maintenance intervention, and the research group included clinical patients who were orally administered to compound ginseng cicada decoction for 1 month, observed for 3 months, and compared with the clinical recurrence (recurrence rate, time to first recurrence, severity at recurrence, degree of pruritus), and the quality of life.
After 3 months, the relapse rate, recurrence severity, itching degree and quality of life impact scores of the study group were significantly lower than those of the control group, and there were no obvious adverse events.
The combined application of compound ginseng cicada decoction in the management of chronic diseases in patients with atopic dermatitis has the positive significance of reducing AD recurrence, alleviating the severity of recurrence, and effectively improving the life quality of patients. This method has high safety and is worthy of wide application.
特应性皮炎（AD）是一种常见的炎症性皮肤病，具有慢性病程和高复发率。
基于“防溃愈疡”理论，回顾性分析复方参蝉汤在 AD 慢性病管理干预中的应用价值及意义。
通过临床回顾性观察，分析 2019 年 1 月以来我院门诊就诊的脾虚湿蕴型 AD 患者 60 例。患者经综合治疗至其研究者整体评估（IGA）评分＜2 分后，按实际临床随访是否服用复方参蝉汤分为研究组和对照组。对照组进行慢性病管理教育，常规润肤剂外用无药物维持干预，研究组则在临床患者中加用口服复方参蝉汤，观察 3 个月，比较临床复发情况（复发率、首次复发时间、复发时严重程度、瘙痒程度）及生活质量。
治疗 3 个月后，研究组复发率、复发时严重程度、瘙痒程度及生活质量影响评分均显著低于对照组，且未见明显不良反应。
复方参蝉汤联合应用于特应性皮炎患者慢性病管理中，具有降低 AD 复发率、减轻复发时严重程度、有效改善患者生活质量的积极意义。该方法安全性高，值得广泛应用。
